MA11.06 A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies
Authors:
- J. ZhangJZJ. Zhang
- C. ZhouCZC. Zhou
- Y. ZhaoYZY. Zhao
- X. MuXMX. Mu
- J. ZhouJZJ. Zhou
- Z. BaoZBZ. Bao
- Y. FanYFY. Fan
- Y. XuYXY. Xu
- Y. ShuYSY. Shu
- R. GuoRGR. Guo
- X. LiuXLX. Liu
- H. WangHWH. Wang
- 1 October 2019
- journal article
- abstracts
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 14 (10) , S292